Literature DB >> 28057293

Fibroepithelial breast lesions diagnosed by core needle biopsy demonstrate a moderate rate of upstaging to phyllodes tumors.

Gabriel Marcil1, Stephanie Wong2, Nora Trabulsi2, Alexandra Allard-Coutu2, Armen Parsyan2, Atilla Omeroglu3, Gulbeyaz Atinel4, Benoit Mesurolle5, Sarkis Meterissian2.   

Abstract

BACKGROUND: Fibroepithelial lesions of the breast (FEL) are atypical lesions diagnosed on core-needle biopsy. The purpose of this study was to determine the rate at which FELs are upstaged to phyllodes tumor on excision, and to examine the clinical and radiological factors that may be predictive of upstaging.
METHODS: A retrospective review from the medical records of patients diagnosed with FEL on CNB at a single institution between 2010 and 2015 was performed. Patients diagnosed with benign or borderline phyllodes tumors were compared to those diagnosed with fibroadenoma.
RESULTS: Of 74 patients diagnosed with FEL, 48 underwent excision (64.9%). Of the 48 lesions excised, pathology revealed 30 fibroadenomas (62.5%), 14 benign phyllodes tumors (29.2%), and 4 borderline phyllodes tumor (8.3%). No malignant phyllodes tumors were identified. On preoperative ultrasound, heterogeneous echotexture (p = 0.03) and lack of internal vascularity (p = 0.03) were significantly associated with upstaging to phyllodes tumor.
CONCLUSIONS: Surgical excision of FELs yield a pathological diagnosis of benign and borderline phyllodes tumor in 37.5% of cases. A high BIRADs score (≥4b), heterogeneous echotexture and lack of internal vascularity on ultrasound may help predict upstaging to phyllodes tumor.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast neoplasms; Core needle biopsy; Excision; Fibroadenoma; Fibroepithelial lesion; Phyllodes tumor

Mesh:

Year:  2016        PMID: 28057293     DOI: 10.1016/j.amjsurg.2016.12.017

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  5 in total

1.  Excision of breast fibroepithelial lesions: when is it still necessary?-A 10-year review of a regional centre.

Authors:  Dorsa Mousa-Doust; Carol K Dingee; Leo Chen; Amy Bazzarelli; Urve Kuusk; Jin-Si Pao; Rebecca Warburton; Elaine C McKevitt
Journal:  Breast Cancer Res Treat       Date:  2022-05-31       Impact factor: 4.872

2.  Computer-Aided Detection of Quantitative Signatures for Breast Fibroepithelial Tumors Using Label-Free Multi-Photon Imaging.

Authors:  Kana Kobayashi-Taguchi; Takashi Saitou; Yoshiaki Kamei; Akari Murakami; Kanako Nishiyama; Reina Aoki; Erina Kusakabe; Haruna Noda; Michiko Yamashita; Riko Kitazawa; Takeshi Imamura; Yasutsugu Takada
Journal:  Molecules       Date:  2022-05-23       Impact factor: 4.927

3.  Fibroepithelial Lesions (FELs) of the Breast: Is Routine Excision Always Necessary?

Authors:  Jessica Limberg; Kelly Barker; Syed Hoda; Rache Simmons; Aya Michaels; Jennifer L Marti
Journal:  World J Surg       Date:  2020-05       Impact factor: 3.352

4.  Can Radiologist and Pathologist Reach The Truth Together in The Diagnosis of Benign Fibroepithelial Lesions?

Authors:  Gamze Durhan; Ömer Önder; Aynur Azizova; Jale Karakaya; Kemal Kösemehmetoğlu; Meltem Gülsün Akpınar; Figen Demirkazık
Journal:  Eur J Breast Health       Date:  2019-07-01

5.  Core needle biopsy in fibroepithelial tumors: predicting factors for phyllodes tumors.

Authors:  Yedda Nunes Reis; Jonathan Yugo Maesaka; Carlos Shimizu; José Maria Soares-Júnior; Edmund Chada Baracat; José Roberto Filassi
Journal:  Clinics (Sao Paulo)       Date:  2021-04-16       Impact factor: 2.365

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.